ABO2011

· Suzhou Abogen Biosciences Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABO2011, covering 2025-08-22 to 2025-08-22. Get the full timeline:

Most recent: Clinical Trial Update: Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors [Phase 1, Phase 2]